RDHL
Closed
Redhill Biopharma Ltd
2.02
+0.08 (+4.12%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.94
Day's Range: 1.9 - 2.084
Send
sign up or login to leave a comment!
When Written:
2.95
RedHill Biopharma Ltd is a biopharmaceutical company that specializes in the development and commercialization of drugs for the treatment of gastrointestinal diseases and cancer. The company was founded in 2009 and is headquartered in Tel Aviv, Israel, with additional offices in the United States.
RedHill Biopharma's product portfolio includes several drugs that are in various stages of development, including RHB-104 for the treatment of Crohn's disease, RHB-204 for the treatment of pulmonary nontuberculous mycobacteria infections, and RHB-105 for the treatment of Helicobacter pylori infection. The company also has a number of other drugs in preclinical development.
In addition to its drug development activities, RedHill Biopharma also has a commercialization division that markets and sells a number of gastrointestinal products in the United States. These products include Donnatal, a prescription drug for the treatment of irritable bowel syndrome, and EnteraGam, a medical food for the treatment of chronic diarrhea and other gastrointestinal disorders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
RedHill Biopharma's product portfolio includes several drugs that are in various stages of development, including RHB-104 for the treatment of Crohn's disease, RHB-204 for the treatment of pulmonary nontuberculous mycobacteria infections, and RHB-105 for the treatment of Helicobacter pylori infection. The company also has a number of other drugs in preclinical development.
In addition to its drug development activities, RedHill Biopharma also has a commercialization division that markets and sells a number of gastrointestinal products in the United States. These products include Donnatal, a prescription drug for the treatment of irritable bowel syndrome, and EnteraGam, a medical food for the treatment of chronic diarrhea and other gastrointestinal disorders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








